By following simplified management guidelines, primary care professionals can easily diagnose and treat HCV, which can only help our patients engage in HCV treatment.
With only a minority of US patients with chronic HBV infection being tested for HDV coinfection, the most critical milestone for identifying patients with HDV is increasing HDV awareness among healthcare workers.
Simplified approaches to HCV treatment help treat and cure HCV in more of our patients and take us closer to the goal of HCV elimination.
Approval of bulevirtide in Europe and promising clinical trial results with lonafarnib signal that new management options for patients with hepatitis delta are on the horizon.
Community engagement and collaboration with healthcare systems can boost uptake of HBV screening and care.
My take on how social determinants of health influence liver disease prevalence, outcomes, and treatment access in the United States; how the COVID-19 pandemic has exacerbated these disparities; and what interventions are needed from healthcare professionals and institutions to address these health inequities.
How I overcame barriers to receiving specialist treatment and care following my diagnosis with chronic HBV infection.
A 3-pronged approach to HCV elimination in MSM patients with HIV and HCV: test, treat, and counsel.
In episode 1 of this ongoing series, listen to a conversation between Stacey Trooskin, MD, PhD, MPH, and patient advocate Brother Dan Palmer on approaches to improve access to HCV therapy and remove barriers to care.